814 results on '"Teknos, Theodoros N."'
Search Results
2. Prognostic significance of time trends in treatment of head and neck squamous cell carcinoma
3. Immediate resection of positive margins improves local control in oral tongue cancer
4. Incidence and medical complications of COVID-19 in the total laryngectomy population: A population-based study
5. High surgical volume is associated with improved survival in head and neck cancer
6. Job market in head and neck surgery: A survey and analysis of recent fellowship graduates
7. Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16− oropharyngeal squamous cell carcinomas
8. Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database
9. Impact of intraoperative ischemia time on acute complications of head and neck microvascular free tissue transfer: A systematic review and meta-analysis
10. Examining timing of periorbital interventions in patients with upper division facial paralysis.
11. Stage Migration and Survival Trends in Laryngeal Cancer
12. HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes
13. The unique and valuable soft tissue free flap in head and neck reconstruction: Lateral arm
14. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma
15. African Americans With p16+ and p16− Oropharyngeal Squamous Cell Carcinomas Have Distinctly Poor Treatment Outcomes Independent of Medical Care Access
16. Appraisal of the AJCC 8th edition pathologic staging modifications for HPV−positive oropharyngeal cancer, a study of the National Cancer Data Base
17. ASO Visual Abstract: Stage Migration and Survival Trends in Laryngeal Cancer
18. Interleukin-6 role in head and neck squamous cell carcinoma progression
19. Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs
20. p53 functional states are associated with distinct aldehyde dehydrogenase transcriptomic signatures
21. Oral Cavity Cancer: Surgical Approaches and Postoperative Treatment
22. Supplementary Figure 4 from YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
23. Data from IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial–Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway
24. Data from LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus–negative Head and Neck Squamous Cell Carcinoma
25. Supplementary Table 3 from YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
26. Supplementary Figure 1 from YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
27. Supplemental Figure Legend from miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma
28. Supplementary Figures 1-2 from IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial–Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway
29. Supplementary Table 2 from YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
30. Supplmental Figure 1 from miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma
31. Supplementary Table 1 from YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
32. Supplementary Figure 5 from YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
33. Data from miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma
34. Supplementary Table 1 and Supplementary Figures 1-7 from LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus–negative Head and Neck Squamous Cell Carcinoma
35. Supplementary Figure 3 from YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
36. Supplementary Figure 2 from YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
37. Supplementary Figure Legend from YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels
38. Supplementary Figure 4 from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
39. Supplementary Data from TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis
40. Supplementary Figures from TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis
41. Supplementary Figure 5 from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
42. Data from TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis
43. Supplementary Table 1 from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
44. Supplementary Figure 1 from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
45. Supplementary Figure 2 from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
46. Supplementary Figure Legend from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
47. Supplementary Figure 3 from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
48. Supplementary Figures from A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma
49. Loss to Follow‐up in Head and Neck Cancer: A Systematic Review of Randomized Controlled Trials
50. NUT Midline Carcinoma of the Sublingual Gland: Clinical Presentation and Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.